Skip to main content
Molecular Therapy Oncolytics logoLink to Molecular Therapy Oncolytics
. 2020 Nov 6;19:178. doi: 10.1016/j.omto.2020.10.013

LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression

Ziran Wang, Wenwei Yu, Yawen Qiang, Liangfei Xu, Fan Ma, Pengsheng Ding, Lan Shi, Wenjiao Chang, Yide Mei, Xiaoling Ma ∗
PMCID: PMC7652721  PMID: 33209977

(Mol Ther Oncolytics. 17, 547–561; June 26, 2020)

In the originally published version of this article, we inadvertently used the wrong image in Figure 1H. The original and corrected versions are shown below. The correction does not affect the result and scientific conclusion of the manuscript. The authors regret this error.

Figure 1H.

Figure 1H

LukS-PV Inhibited the Proliferation of HCC Cells that Express C5aR (Corrected)

Figure 1H.

Figure 1H

LukS-PV Inhibited the Proliferation of HCC Cells that Express C5aR (Original)


Articles from Molecular Therapy Oncolytics are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES